Jan Balzarini

39.0k total citations · 2 hit papers
872 papers, 33.4k citations indexed

About

Jan Balzarini is a scholar working on Infectious Diseases, Virology and Organic Chemistry. According to data from OpenAlex, Jan Balzarini has authored 872 papers receiving a total of 33.4k indexed citations (citations by other indexed papers that have themselves been cited), including 516 papers in Infectious Diseases, 331 papers in Virology and 330 papers in Organic Chemistry. Recurrent topics in Jan Balzarini's work include HIV/AIDS drug development and treatment (506 papers), HIV Research and Treatment (326 papers) and Biochemical and Molecular Research (186 papers). Jan Balzarini is often cited by papers focused on HIV/AIDS drug development and treatment (506 papers), HIV Research and Treatment (326 papers) and Biochemical and Molecular Research (186 papers). Jan Balzarini collaborates with scholars based in Belgium, United Kingdom and Spain. Jan Balzarini's co-authors include Erik De Clercq, Robert Snoeck, Dominique Schols, Rudi Pauwels, Masanori Baba, Piet Herdewijn, Graciela Andreï, Antonı́n Holý, Christophe Pannecouque and Jan Desmyter and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Jan Balzarini

860 papers receiving 32.4k citations

Hit Papers

Rapid and automated tetrazolium-based colorimetric assay ... 1986 2026 1999 2012 1988 1986 500 1000 1.5k

Peers

Jan Balzarini
Hiroaki Mitsuya United States
Raymond F. Schinazi United States
Johan Neyts Belgium
Rudi Pauwels Belgium
Ting‐Chao Chou United States
Hiroaki Mitsuya United States
Jan Balzarini
Citations per year, relative to Jan Balzarini Jan Balzarini (= 1×) peers Hiroaki Mitsuya

Countries citing papers authored by Jan Balzarini

Since Specialization
Citations

This map shows the geographic impact of Jan Balzarini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Balzarini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Balzarini more than expected).

Fields of papers citing papers by Jan Balzarini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Balzarini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Balzarini. The network helps show where Jan Balzarini may publish in the future.

Co-authorship network of co-authors of Jan Balzarini

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Balzarini. A scholar is included among the top collaborators of Jan Balzarini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Balzarini. Jan Balzarini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weber, Stefan, et al.. (2020). Prodrugs of γ‐Alkyl‐Modified Nucleoside Triphosphates: Improved Inhibition of HIV Reverse Transcriptase. Angewandte Chemie International Edition. 59(49). 22063–22071. 17 indexed citations
2.
3.
Gangarapu, Kiran, Sarangapani Manda, Sreekanth Thota, et al.. (2013). Synthesis of thiocarbohydrazide and carbohydrazide derivatives as possible biologically active agents. Medicinal Chemistry Research. 23(2). 1046–1056. 38 indexed citations
4.
Férir, Geoffrey, Dana Huskens, Kenneth E. Palmer, et al.. (2012). Combinations of Griffithsin with Other Carbohydrate-Binding Agents Demonstrate Superior Activity Against HIV Type 1, HIV Type 2, and Selected Carbohydrate-Binding Agent-Resistant HIV Type 1 Strains. AIDS Research and Human Retroviruses. 28(11). 1513–1523. 37 indexed citations
5.
Singh, Kamaljit, Kawaljit Singh, Baojie Wan, et al.. (2011). Facile transformation of Biginelli pyrimidin-2(1H)-ones to pyrimidines. In vitro evaluation as inhibitors of Mycobacterium tuberculosis and modulators of cytostatic activity. European Journal of Medicinal Chemistry. 46(6). 2290–2294. 66 indexed citations
6.
Balzarini, Jan, et al.. (2011). Diastereoselective Synthesis of (Aryloxy)phosphoramidate Prodrugs. European Journal of Organic Chemistry. 2011(25). 4899–4909. 18 indexed citations
7.
Janeba, Zlatko, Antonı́n Holý, Radek Pohl, et al.. (2010). Synthesis and biological evaluation of acyclic nucleotide analogues with a furo[2,3- d ]pyrimidin-2(3 H )-one base. Canadian Journal of Chemistry. 88(7). 628–638. 15 indexed citations
8.
Huskens, Dana, et al.. (2007). Safety concerns for the potential use of cyanovirin as a microbicidal anti-HIV agent. 451. 1 indexed citations
9.
Gisch, Nicolas, et al.. (2006). Enzymatically activated cycloSal-pronucleotides. Antiviral Research. 70.
10.
Rosen, T.C., et al.. (2004). Synthesis and antiviral activity of monofluorinated cyclopropanoid nucleosides. Organic & Biomolecular Chemistry. 2(2). 229–229. 9 indexed citations
11.
Reid, Glen, Peter R. Wielinga, Noam Zelcer, et al.. (2003). Characterization of the Transport of Nucleoside Analog Drugs by the Human Multidrug Resistance Proteins MRP4 and MRP5. Molecular Pharmacology. 63(5). 1094–1103. 300 indexed citations
12.
McGuigan, Christopher, Ranjith Pathirana, Erik De Clercq, & Jan Balzarini. (2003). Discovery of a new family of bicyclic dideoxy nucleosides which inhibit HCMV by a non-nucleoside mechanism. Antiviral Research. 57. 1 indexed citations
13.
Manallack, David T., William R. Pitt, Piet Herdewijn, et al.. (2002). Database Searching for Thymidine and Thymidylate Kinase Inhibitors Using Three-dimensional Structure-based Methods. Journal of Enzyme Inhibition and Medicinal Chemistry. 17(3). 167–174. 5 indexed citations
14.
Tronchet, Jean M. J., Imre Kovács, Pierre J. Dilda, et al.. (2001). SYNTHESIS AND ANTI-HIV ACTIVITY OF THYMIDINE ANALOGUES BEARING A 4′-CYANOVINYL GROUP AND SOME DERIVATIVES THEREOF. Nucleosides Nucleotides & Nucleic Acids. 20(12). 1927–1939. 6 indexed citations
15.
Balzarini, Jan & Erik De Clercq. (2001). Rapid Alternation of Drug Therapy Is Highly Efficient in Suppressing the Emergence of Mutant Drug-Resistant HIV Strains in Cell Culture. AIDS Research and Human Retroviruses. 17(17). 1625–1634. 2 indexed citations
16.
Laethem, Kristel Van, Jean‐Claude Schmit, Heidi Pelemans, et al.. (2000). Presence of 2' ,5'-Bis- O -( tert -butyldimethylsilyl)-3-spiro-5"(4"-amino-1",2"-oxathiole-2",2"-dioxide) (TSAO)-Resistant Virus Strains in TSAO-Inexperienced HIV Patients. AIDS Research and Human Retroviruses. 16(9). 825–833. 3 indexed citations
18.
Bergamini, Alberto, Carlo Federico Perno, Jan Balzarini, et al.. (1992). Selective Inhibition of HIV Replication by Adriamycin in Macrophages But Not in Lymphocytes. AIDS Research and Human Retroviruses. 8(7). 1239–1247. 9 indexed citations
19.
Neyts, Johan, Robert Snoeck, Dominique Schols, et al.. (1992). Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate. Virology. 189(1). 48–58. 141 indexed citations
20.
Naesens, Lieve, Jan Balzarini, & Erik De Clercq. (1992). Pharmacokinetics in mice of the anti-retrovirus agent 9-(2-phosphonylmethoxyethyl)adenine.. Drug Metabolism and Disposition. 20(5). 747–752. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026